...
首页> 外文期刊>International journal of geriatric psychiatry >Debate article: Antipsychotic medications are clinically useful for the treatment of delirium
【24h】

Debate article: Antipsychotic medications are clinically useful for the treatment of delirium

机译:辩论文章:抗精神病药在临床上可用于治疗谵妄

获取原文
获取原文并翻译 | 示例
           

摘要

Prescribing of antipsychotic medications for patients with delirium remains controversial. Concerns exist that these vulnerable and frail patients may be prescribed antipsychotics inappropriately as a substitute for non‐pharmacological approaches when identifiable causes are not found or they challenge ward processes. Moreover, recent evidence suggests that antipsychotics may cause more harm than good in the palliative care patient group with delirium. On the other hand, guidelines in the United Kingdom and the Netherlands support prescribing of antipsychotics in certain circumstances, and a large European survey has revealed that antipsychotics tend to be prescribed first line for hyperactive delirium. Never before, therefore, is there a greater need to examine whether indeed these medications are clinically useful for the treatment of delirium. With this in mind, evidence‐based arguments for and against prescribing antipsychotics for the treatment of delirium are presented in this debate article. The paper concludes with a moderation piece to help guide clinical practice.
机译:谵妄患者的抗精神病药物的规定仍然存在争议。存在担心,这些脆弱的患者可以在未发现可识别原因或挑战病房程序时,作为非药理学方法的替代品。此外,最近的证据表明,抗精神病药可能在嗜睡中姑息治疗患者组中的损害良好。另一方面,英国和荷兰在某些情况下支持抗精神病药的指导方针,欧洲欧洲调查显示,抗精神病药倾向于为过度活跃的谵妄规定一线。因此,从来没有任何需要检查是否这些药物是临床上可用于治疗谵妄的临床上。考虑到这一点,在本次辩论文章中提出了基于证据的论据和反对规定谵妄的抗精神病学。本文结束了促使指导临床实践的适度件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号